FDA Plans to Prioritize Laboratory Safety in Safety Initiative Overhaul
The agency’s upcoming changes will be an effort to continue innovations that became necessary because of COVID-19.
- By Nikki Johnson-Bolden
- Oct 16, 2020
The FDA announced measures to confirm its commitment to protect public health in a statement from the Commissioner of Food and Drugs on October 8.
In the statement, Stephen M. Hahn M.D. announces a new cross-agency working group that will review the FDA’s current structure and strategize on ways to improve areas like occupational health and safety and laboratory safety.
The FDA’s Office of Laboratory Safety (OLS) will also be working to improve laboratory safety and security.
These changes arrive after the agency received recommendations on laboratory safety in the form of a report from the Government Accountability Office. The FDA will use the recommendations to update its current OLS plan.
For more information on the FDA’s safety measurement modifications, visit fda.gov.
Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.